Table 2.
Baseline clinical indicators before convalescent plasma transfusion
| Patient no. | WBC (×109/L) | Lym. (×109/L) | AST (U/L) | LDH (U/L) | CK (U/L) | Creatinine (umol/L) | CRP (mg/L) | CT presentation of lungs | Range of lesions in lungs |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 5.79 | 1.62 | 22 | 187 | 40 | 57 | 0.66 | Ground-glass opacity | <50% |
| 2 | 14.79 | 0.74 | 23 | 931 | 33 | 69 | 123.8 | Ground-glass opacity | <50% |
| 3 | 2.74 | 0.67 | 37 | 269 | 33 | 70 | 3.23 | Pulmonary parenchymal consolidation, predominantly subpleural | <50% |
| 4 | 4.48 | 1.27 | 26 | 199 | 48 | 66 | 1.7 | Ground-glass opacity | >50% |
| 5 | 6.69 | 0.98 | 58 | 362 | 62 | 67 | 113.3 | Ground-glass opacity | <50% |
| 6 | 8.29 | 1.14 | 15 | 291 | 25 | 56 | 32.6 | Ground-glass opacity | <50% |
| 7 | 10.31 | 0.74 | 28 | 305 | 56 | 150 | 92.5 | Ground-glass opacity | <50% |
| 8 | 6.10 | 0.51 | 51 | 428 | 94 | 59 | 68.3 | Ground-glass opacity | <50% |
Abbreviations: AST, aspartate aminotransferase; CK, creatine kinase; CP, convalescent plasma; CRP, C-reactive protein; LDH, lactate dehydrogenase; Lym., lymphocyte count; WBC, white blood cell count.